the premium on those two are not comparable to Neuren. Mayne pharm has been operating at a loss for a number of years now and domain is not exactly a high growth stock. Biotech typically attracts much higher take over premium especially after phase 3 end points are confirmed
NEU Price at posting:
$13.27 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)